ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced updated efficacy and safety ...
We're still piecing together what caused Verizon's extended service blackout, but network experts point to possibilities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback